Beijing Allcure Completes $103 Million Funding for China Oncology Centers

Beijing Allcure Medical completed a $103 million Series B round to support its standardized programs for China oncology imaging and radiation therapy treatment centers. Allcure Medical offers comprehensive plans for radiology services to hospitals via its mdaccAutoPlan Radiotherapy Plan Algorithm, which includes everything from construction planning to standardized treatment plans and online consultation. China Capital Investment Group, a subsidiary of CICC, led the round. More details....

Share this with colleagues:

More From BioPortfolio on "Beijing Allcure Completes $103 Million Funding for China Oncology Centers"